Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amag Pharmaceuticals (AMAG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 711,806
  • Shares Outstanding, K 34,470
  • Annual Sales, $ 609,950 K
  • Annual Income, $ -199,230 K
  • 36-Month Beta 0.48
  • Price/Sales 1.18
  • Price/Cash Flow N/A
  • Price/Book 0.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.63
  • Number of Estimates 4
  • High Estimate -0.41
  • Low Estimate -0.85
  • Prior Year 1.57
  • Growth Rate Est. (year over year) -140.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.25 +1.98%
on 09/19/18
25.20 -18.06%
on 08/24/18
-4.10 (-16.57%)
since 08/21/18
3-Month
19.10 +8.12%
on 07/02/18
26.10 -20.88%
on 08/13/18
-0.48 (-2.25%)
since 06/21/18
52-Week
11.93 +73.17%
on 11/02/17
26.10 -20.88%
on 08/13/18
+2.20 (+11.92%)
since 09/21/17

Most Recent Stories

More News
AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that together with Emmy(R)-nominated actress Cheryl Hines and leading family medicine and menopause expert, Marla Shapiro, MD, it is launching an...

AMAG : 20.65 (-1.20%)
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic...

PTN : 1.00 (-2.91%)
AMAG : 20.65 (-1.20%)
AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has redeemed $475 million of its outstanding 7.875% senior notes, using the proceeds from the sale of Cord Blood Registry(R), which closed...

AMAG : 20.65 (-1.20%)
Options Traders Expect Huge Moves in AMAG Pharmaceuticals (AMAG) Stock

AMAG Pharmaceuticals (AMAG) needs investors to pay close attention to the stock based on moves in the options market lately.

AMAG : 20.65 (-1.20%)
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences:

AMAG : 20.65 (-1.20%)
Factors of Influence in 2018, Key Indicators and Opportunity within AMAG Pharmaceuticals, Pier 1 Imports, Gogo, IDT, Axalta Coating, and Sprouts Farmers Market -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AMAG Pharmaceuticals, Inc....

GOGO : 5.43 (-4.40%)
PIR : 1.45 (-19.89%)
IDT : 5.26 (+0.57%)
AXTA : 30.70 (+1.15%)
SFM : 27.54 (+0.07%)
AMAG : 20.65 (-1.20%)
California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform

California Cryobank, the world's leading donor sperm and donor egg bank, announced today that it has been acquired by GI Partners, a private equity investment firm, from leading healthcare investors Longitude...

AMAG : 20.65 (-1.20%)
AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry(R)

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has closed the previously announced divestiture of Cord Blood Registry (CBR(R)) to GI Partners, a private equity investment firm, for $530 million...

AMAG : 20.65 (-1.20%)
AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Brian Robinson, M.D. as senior vice president, medical affairs, reporting into Julie Krop, M.D., chief medical officer and executive...

AMAG : 20.65 (-1.20%)
AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates

AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of -257.14% and -6.90%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

AMAG : 20.65 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AMAG with:

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

2nd Resistance Point 21.62
1st Resistance Point 21.13
Last Price 20.65
1st Support Level 20.31
2nd Support Level 19.97

See More

52-Week High 26.10
Fibonacci 61.8% 20.69
Last Price 20.65
Fibonacci 50% 19.01
Fibonacci 38.2% 17.34
52-Week Low 11.93

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar